Status:
COMPLETED
Hesperidin and Bone Health in Postmenopausal Women
Lead Sponsor:
Purdue University
Collaborating Sponsors:
Nestec Ltd.
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The primary objective of this clinical trial is to test hesperidin with and without CALCILOCK® for bone resorption suppressing effect in postmenopausal women. The secondary objective is the comparison...
Detailed Description
Subjects will participate in four phases of the study: Baseline of 50 days and three intervention phases which include 50 days receiving product followed by 50 days of recovery. The total duration of ...
Eligibility Criteria
Inclusion
- Women at least 4 years postmenopausal
Exclusion
- Medications affecting bone resorption
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01881204
Start Date
April 1 2011
End Date
October 1 2012
Last Update
May 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purdue University
West Lafayette, Indiana, United States, 47907